Sort
27,075 grants matching “cholesterol”
Neurosteroids in health and disease
$498,719Synthia H Mellon · University Of California, San Francisco · U01 · FY2006 · NS
Investigating the potential impact of a low-fat high fiber diet in limiting TBI-induced neurodegenerative and inflammatory changes.
$498,713Nimish Kumar Acharya · Rowan University School/Osteopathic Med · R15 · FY2024 · NS
Project 1: Discovery of proteins with altered abundance and stability
$498,693Michael J Maccoss · University Of Washington · U19 · FY2020 · AG
The Functional Interplay of Lipid Membrane Components: Activation, Inhibition, and Raft Formation.
$498,400Benjamin James Wylie · Texas Tech University · R35 · FY2023 · GM
Effect of Prescription Drug Benefits on Cardiovascular Outcomes in the Elderly
$498,387Amal N. Trivedi · Brown University · RC1 · FY2009 · AG
Mechanism of ABCA1-mediated CEC to lipidated HDL particles
$498,327W. Sean Davidson · University Of Cincinnati · P01 · FY2025 · HL
Dietary Cholesterol and Defects in Cholesterol Synthesis
$498,316Robert David Steiner · Oregon Health & Science University · R01 · FY2011 · HL
Structure-Function Relationship Studies of the Plasma Lipid Transfer Proteins CETP and PLTP
$498,306Gang Ren · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2018 · HL
Metabolic Syndrome in Childhood Cancer Survivors
$498,228Julia Steinberger · University Of Minnesota · R01 · FY2010 · CA
The molecular basis for the role of apolipoprotein A-II in cholesterol and triglyceride metabolism
$498,218W. Sean Davidson · University Of Cincinnati · R01 · FY2022 · HL
The molecular basis for the role of apolipoprotein A-II in cholesterol and triglyceride metabolism
$498,218W. Sean Davidson · University Of Cincinnati · R01 · FY2023 · HL
Id3/B Lymphocytes and Atherosclerosis
$498,195Coleen A McNamara · University Of Virginia · R01 · FY2010 · HL
STATINS AND ACE INHIBITORS IN ADULTS WITH DIABETES AND COMORBID CONDITIONS
$498,183David E Grembowski · University Of Washington · R21 · FY2010 · HS
Diet, Endothelial Function and Pediatric Hyperlipidemia
$498,160Marguerite Maryanne Engler · University Of California, San Francisco · R56 · FY2008 · NR
Endosomal lysosomal function in neuronal storage disease
$498,117Steven Upshaw Walkley · Albert Einstein College Of Medicine · R01 · FY2021 · HD
A Cardiovascular Risk Reduction Learning Community in DARTNet
$498,104Karl Hammermeister · University Of Colorado Denver · RC1 · FY2010 · HL
Genetic Markers of CHD in Type 2 Diabetes
$498,073Lu Qi · Harvard School Of Public Health · R01 · FY2009 · HL
Core--Clinical resources
$498,057Southwest Foundation For Biomedical Res · P01 · FY2002 · HL
Genetic analysis of CVD risk factors
$498,057Southwest Foundation For Biomedical Res · P01 · FY2002 · HL
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease
$498,026Leslee J Shaw · Emory University · RC1 · FY2009 · HL
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
$498,020Rima F Kaddurah-Daouk · Duke University · RF1 · FY2016 · AG
The structural basis for cholesterol esterification in human plasma
$497,982W. Sean Davidson · University Of Cincinnati · R01 · FY2020 · HL
Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease
$497,966Leslee J Shaw · Emory University · RC1 · FY2010 · HL
DIET AND GENOTYPE IN PRIMATE ATHERSCLEROSIS: VETERINARY SERVICES
$497,818Karen S Rice · Texas Biomedical Research Institute · P51 · FY2010 · RR
Metabolic Syndrome in Childhood Cancer Survivors
$497,815Julia Steinberger · University Of Minnesota · R01 · FY2009 · CA